These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 30758123

  • 1. Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.
    Khan SA, Ci B, Xie Y, Gerber DE, Beg MS, Sherman SI, Cabanillas ME, Busaidy NL, Burtness BA, Heilmann AM, Bailey M, Ross JS, Sher DJ, Ali SM.
    Head Neck; 2019 Jun; 41(6):1928-1934. PubMed ID: 30758123
    [Abstract] [Full Text] [Related]

  • 2. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
    Latteyer S, Tiedje V, König K, Ting S, Heukamp LC, Meder L, Schmid KW, Führer D, Moeller LC.
    Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
    [Abstract] [Full Text] [Related]

  • 3. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R.
    Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
    [Abstract] [Full Text] [Related]

  • 4. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H, Li Y, Hu P, Gao J, Ying J, Xu W, Zhao D, Wang Z, Ye J, Lizaso A, He Y, Wu H, Liang Z.
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [Abstract] [Full Text] [Related]

  • 5. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
    Vanden Borre P, Schrock AB, Anderson PM, Morris JC, Heilmann AM, Holmes O, Wang K, Johnson A, Waguespack SG, Ou SI, Khan S, Fung KM, Stephens PJ, Erlich RL, Miller VA, Ross JS, Ali SM.
    Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
    Bonhomme B, Godbert Y, Perot G, Al Ghuzlan A, Bardet S, Belleannée G, Crinière L, Do Cao C, Fouilloux G, Guyetant S, Kelly A, Leboulleux S, Buffet C, Leteurtre E, Michels JJ, Tissier F, Toubert ME, Wassef M, Pinard C, Hostein I, Soubeyran I.
    Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
    Jeon MJ, Chun SM, Kim D, Kwon H, Jang EK, Kim TY, Kim WB, Shong YK, Jang SJ, Song DE, Kim WG.
    Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1.
    Saito Y, Kage H, Kobayashi K, Kamogashira T, Fukuoka O, Yamamura K, Yamashita S, Tanabe M, Oda K, Kondo K.
    Clin Endocrinol (Oxf); 2024 Aug; 101(2):170-179. PubMed ID: 38853441
    [Abstract] [Full Text] [Related]

  • 11. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
    Yoo SK, Song YS, Lee EK, Hwang J, Kim HH, Jung G, Kim YA, Kim SJ, Cho SW, Won JK, Chung EJ, Shin JY, Lee KE, Kim JI, Park YJ, Seo JS.
    Nat Commun; 2019 Jun 24; 10(1):2764. PubMed ID: 31235699
    [Abstract] [Full Text] [Related]

  • 12. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.
    Sandulache VC, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cote GJ, Singh RR, Luthra R, Cabanillas ME.
    Thyroid; 2017 Jan 24; 27(1):81-87. PubMed ID: 27785980
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
    Kunstman JW, Juhlin CC, Goh G, Brown TC, Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams C, Mane S, Rimm DL, Prasad ML, Höög A, Zedenius J, Larsson C, Korah R, Lifton RP, Carling T.
    Hum Mol Genet; 2015 Apr 15; 24(8):2318-29. PubMed ID: 25576899
    [Abstract] [Full Text] [Related]

  • 14. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
    Smith N, Nucera C.
    J Clin Endocrinol Metab; 2015 Jan 15; 100(1):35-42. PubMed ID: 25347569
    [Abstract] [Full Text] [Related]

  • 15. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
    Abe I, Lam AK.
    Curr Oncol Rep; 2021 Feb 13; 23(3):31. PubMed ID: 33582932
    [Abstract] [Full Text] [Related]

  • 16. Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
    Shi X, Liu R, Qu S, Zhu G, Bishop J, Liu X, Sun H, Shan Z, Wang E, Luo Y, Yang X, Zhao J, Du J, El-Naggar AK, Teng W, Xing M.
    J Clin Endocrinol Metab; 2015 Apr 13; 100(4):E632-7. PubMed ID: 25584719
    [Abstract] [Full Text] [Related]

  • 17. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
    Xu B, Ghossein R.
    Endocr Pathol; 2016 Sep 13; 27(3):205-12. PubMed ID: 27372303
    [Abstract] [Full Text] [Related]

  • 18. Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.
    Woodward EL, Biloglav A, Ravi N, Yang M, Ekblad L, Wennerberg J, Paulsson K.
    Endocr Relat Cancer; 2017 May 13; 24(5):209-220. PubMed ID: 28235956
    [Abstract] [Full Text] [Related]

  • 19. Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer.
    Zhang L, Ren Z, Su Z, Liu Y, Yang T, Cao M, Jiang Y, Tang Y, Chen H, Zhang W, Gong R, Wei T, Peng Y, Liu B, Zhang W, Yang L, Hu Y, Li Z, Zhu J, Xu H, Shu Y, Luo H.
    J Clin Endocrinol Metab; 2021 Mar 25; 106(4):988-998. PubMed ID: 33428730
    [Abstract] [Full Text] [Related]

  • 20. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
    Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4652-e4665. PubMed ID: 34147031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.